Author(s): Cénat JM; Noorishad PG; Bakombo SM; Onesi O; Mesbahi A; Darius WP; Caulley L; Yaya S; Chomienne MH; Etowa J; Venkatesh V; Dalexis RD; Pongou R; Labelle PR;

Black communities have been disproportionately impacted by Coronavirus Disease 2019 (COVID-19) in Canada, in terms of both number of infections and mortality rates. Yet, according to early studies, vaccine hesitancy appears to be higher in Black communities. The purpose of this systematic review ...

Article GUID: 36423032

Author(s): Vallis M; Bacon S; Corace K; Joyal-Desmarais K; Sheinfeld Gorin S; Paduano S; Presseau J; Rash J; Mengistu Yohannes A; Lavoie K;

Governments, public health officials and pharmaceutical companies have all mobilized resources to address the COVID-19 pandemic. Lockdowns, social distancing, and personal protective behaviours have been helpful but have shut down economies and disrupted normal activities. Vaccinations protect po ...

Article GUID: 35062668

Author(s): Azarpanah H; Farhadloo M; Vahidov R; Pilote L;

Background: Vaccine hesitancy has been a growing challenge for public health in recent decades. Among factors contributing to vaccine hesitancy, concerns regarding vaccine safety and Adverse Events (AEs) play the leading role. Moreover, cognitive biases are critical in connecting such concerns to vaccine hesitancy behaviors, but their role has not been co ...

Article GUID: 34530804

Author(s): Stojanovic J; Boucher VG; Gagne M; Gupta S; Joyal-Desmarais K; Paduano S; Aburub AS; Sheinfeld Gorin SN; Kassianos AP; Ribeiro PAB; Bacon SL; Lavoie KL;

The success of large-scale COVID-19 vaccination campaigns is contingent upon people being willing to receive the vaccine. Our study explored COVID-19 vaccine hesitancy and its correlates in eight different countries around the globe. We analyzed convenience sample data collected between March 202 ...

Article GUID: 34204379